These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18484799)

  • 21. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting nicotine addiction: the possibility of a therapeutic vaccine.
    Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM
    Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum].
    Aparici M; Fernández González AL; Alegría E
    Rev Clin Esp; 1994 Jun; 194(6):453-6. PubMed ID: 8079014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
    Chiamulera C; Marzo CM; Balfour DJK
    Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in pharmacotherapy for tobacco dependence.
    Foulds J; Burke M; Steinberg M; Williams JM; Ziedonis DM
    Expert Opin Emerg Drugs; 2004 May; 9(1):39-53. PubMed ID: 15155135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.
    Li X; Semenova S; D'Souza MS; Stoker AK; Markou A
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):554-65. PubMed ID: 23752091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking cessation pharmacotherapy.
    Frishman WH
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):287-308. PubMed ID: 19491139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
    Rehni AK; Singh TG; Arora S
    Nicotine Tob Res; 2012 Apr; 14(4):407-14. PubMed ID: 22102627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current pharmacological treatments for nicotine dependence.
    George TP; O'Malley SS
    Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for nicotine dependence.
    Henningfield JE; Fant RV; Buchhalter AR; Stitzer ML
    CA Cancer J Clin; 2005; 55(5):281-99; quiz 322-3, 325. PubMed ID: 16166074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in non-nicotine pharmacotherapy for smoking cessation.
    Covey LS; Sullivan MA; Johnston JA; Glassman AH; Robinson MD; Adams DP
    Drugs; 2000 Jan; 59(1):17-31. PubMed ID: 10718098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC; Shoaib M
    Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New mechanisms and perspectives in nicotine withdrawal.
    Jackson KJ; Muldoon PP; De Biasi M; Damaj MI
    Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.
    Escobar-Chávez JJ; Merino V; López-Cervantes M; Rodríguez-Cruz IM; Quintanar-Guerrero D; Ganem-Quintanar A
    Curr Drug Discov Technol; 2009 Sep; 6(3):171-85. PubMed ID: 19496753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine and non-nicotine smoking cessation pharmacotherapies.
    Frishman WH; Mitta W; Kupersmith A; Ky T
    Cardiol Rev; 2006; 14(2):57-73. PubMed ID: 16493243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine replacement therapy.
    Fant RV; Owen LL; Henningfield JE
    Prim Care; 1999 Sep; 26(3):633-52. PubMed ID: 10436291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug aid to tobacco withdrawal].
    Bobrie G; Battaglia C; Loufrani E; Ménard J
    Rev Prat; 1993 May; 43(10):1238-44. PubMed ID: 8235362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging drugs for the treatment of tobacco dependence.
    Ebbert JO
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):23-32. PubMed ID: 19278367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.